Evaluation of pseudoprogression rates and tumor progression patterns in a phase III trial of bevacizumab plus radiotherapy/temozolomide for newly diagnosed glioblastoma - Wick, Wolfgang; Bendszus, Martin (Neuro-Oncology, 2016)
Gesehen am 22.11.2017